Walgreens Boots Alliance (NASDAQ: WBA) reported third quarter 2020 earnings results today.
Sales increased 0.1% year-over-year to $34.6 billion. Sales growth was 1.2% on a constant currency basis, led by Retail Pharmacy USA comparable sales growth of 3%. The adverse impact of COVID-19 on sales was approx. $700-750 million, with the majority of the impact related to the Retail Pharmacy International division.
Stay tuned here for WBA Q3 2020 Earnings Transcript
Net loss attributable to WBA was $1.7 billion, or $1.95 per share, compared to earnings of $1 billion, or $1.13 per share, a year ago. Adjusted net earnings attributable to WBA decreased 45.9% to $723 million and adjusted EPS fell 43.8% to $0.83.
For fiscal 2020, adjusted EPS is expected to be $4.65 to $4.75, including estimated adverse COVID-19 impacts of $1.03-1.14 per share.
The board of directors declared a quarterly dividend of 46.75 cents per share, up 2.2%. The dividend is payable on September 11, 2020 to stockholders of record as of August 19, 2020, and raises the annual rate from $1.83 per share to $1.87 per share. The company is also suspending activity under its share repurchase program.
Most Popular
STZ Earnings Preview: Can Constellation Brands leverage growing beer sales?
Constellation Brands, Inc. (NYSE: STZ) has effectively navigated challenges like cautious consumer spending and declining demand for its wine and spirits brands by capitalizing on the sustained growth in the
What to look for when Lamb Weston (LW) reports its Q3 2025 earnings results
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) stayed green on Friday. The stock has dropped 19% over the past three months. The French fry giant is slated to report
Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results, with market watchers forecasting a mixed outcome. As part of
